Class, Davis & Leon (2022) report about three-fourths of all lifetime mental

Class, 

Davis & Leon (2022) report about three-fourths of all lifetime mental health disorders develop in childhood, with half starting by 14. A large percentage of children who develop symptoms remain undetected and go untreated. The National Alliance on Mental Illness states the average time between the appearance of the first symptoms and intervention is about 11 years of age. Based on the evidence and clinical practice, NPs must support early mental health screening. 

Davis, L. L., & Leon, M. (2022). Depression screening in adolescents: Implications for primary care nurse practitioners. The Journal for Nurse Practitioners, Volume 18, Issue 3, pp 259-264. https://doi.org/10.1016/j.nurpra.2021.12.003. 

Question:

Have you had any experiences screening adolescents or school-aged children in your clinical setting for depression? If so, or even if not which screening tool and class of medications have you ordered? What side effects would you be concerned about when ordering this class of medications for children or adolescents? 

NOTE: I have not had any experience with screening for depressed adolescents in my clinical setting yet.

Cite your response with the evidence by responding to this thread.